2-minute overview
What is FasciaClinics?
The Problem
Medicine Divided the Body. Nobody Sees the Whole.
Modern medicine has fragmented the body into specialities — orthopaedics, neurology, rheumatology, physiotherapy. Each specialist owns a part. Nobody owns the connective system that ties everything together.
Fascia — the connective tissue network running through the entire body — is the missing anatomical link. Conditions like Frozen Shoulder, chronic tension, and restricted mobility often originate here. Patients cycle through specialists indefinitely. Our pilot study on Frozen Shoulder shows measurably improved functional outcomes after fascia-based treatment.
"Stefan Sallerfors, our Chairman and radiologist with insurance medicine background, confirmed immediately: this is exactly the problem the insurance industry needs solved."
— Axel Bohlin, CSO
Multiple International Awards
German Design Award 2020 · Good Design Award 2018
The Solution
The First Scalable System for Fascia-Based Care
FasciaClinics combines proprietary technology, standardised treatment protocols, and a franchise model to make fascia-based care reproducible, trainable, and scalable — for the first time in history.
Atlasbalans Technology
Patented mechanism. German Design Award 2020. Good Design Award 2018. The only device of its kind — reproducible outcomes, trainable in weeks.
Standardised Protocol
Treatment outcomes are reproducible across all clinics. This is what makes franchise possible at scale.
Clinic-in-a-Box
Modular unit. Deployable in hotels, gyms, spas, airports. Designed for quality-assured autonomous operations from day one.
AI-Driven Knowledge Platform
Fascia Guide: 250+ hours of expert podcast content. Research Database: 5,000+ curated articles. Each new therapist strengthens the network.
Market Opportunity
A Blue Ocean in a €5.5 Trillion Market
Fascia is scientifically validated but commercially underdeveloped. Medicine has divided the body into specialities — no one owns the whole. FasciaClinics is the category creator.
TAM
€5.5T
Global wellness market (GWI 2024)
Growing ~10% annually
SAM
€180B
Therapeutic bodywork, rehabilitation, sports recovery
Addressable via clinic network
SOM
€2.4B
500 clinics × €4.8M average revenue
10-year expansion horizon
The Sweden Proof
Sweden is one of the world's most competitive markets for new concepts — not because Swedes are slow to adopt, but because they adopt everything fast. The market is saturated with trends. Spotify, Klarna, King (Candy Crush), and Mojang (Minecraft) all proved their model here before going global. Swedes were famously sceptical about gambling — today Sweden is among the world's most active gaming markets. FasciaClinics has done the same — 16 years, 100,000+ treatments, profitable franchise, without external capital until now. If it survives Sweden, it scales everywhere.
Business Model
Revenue Streams
FasciaClinics earns on every treatment performed anywhere in the world — and on every new market that opens.
Royalty per Treatment
Active nowA percentage of every treatment performed across all active clinics — globally. As the network grows, so does the royalty base. Long-term, this becomes a recurring income stream from every fascia treatment delivered worldwide.
Unit Startup Fee
Per new unitEach new clinic pays a startup fee to access the FasciaClinics system — training, protocols, technology, brand. Every new unit that opens generates an upfront revenue event for the franchisor.
Master Franchise License
Per new marketWhen a partner acquires rights to a country or region — for example, the Netherlands or a part of Germany — they pay an upfront license fee. This is the highest-margin revenue event in the model.
Clinic Formats
Entry-level clinic. Single-session treatments. Broad consumer audience. Rapid break-even.
Multi-session treatment programmes. Higher average transaction value. Targets chronic conditions and performance recovery.
Premium full-service clinic. Combines all treatment modalities. Serves as market anchor and brand showcase.
The Ecosystem
Fascia Guide (250+ hours of expert podcasts) · Fascia Research Database (5,000+ articles) · Fascia Vibes · Atlasbalans · Fascia Academy — each part strengthens the others, creating a system that is structurally difficult to replicate.
Unit Economics — Per Clinic
Annual Revenue
SEK 1.5–2.5M
Time to autonomous ops
1–2 months (top clinics)
Franchisee ROI
12–18 months
Capital to open
SEK 400–600K
Traction & Proof Points
100,000+ Treatments. 16 Years. Built on Community Capital.
FasciaClinics raised SEK 12M through crowdfunding — with approximately 500 external shareholders now owning ~10% of the company. For that capital, we built a complete, internationally scalable franchise system. Valuation has grown from SEK 100M to SEK 265M over four years.
Competitive Position
16 Years Ahead. Structurally Defensible.
Individual competitors may have one element. None have all four moats. The combination takes a decade to replicate.
◆
Knowledge Moat
16 years of accumulated clinical knowledge. 100,000+ treatments. Proprietary protocols refined across dozens of clinics, built with hundreds of experts. No competitor can replicate this without a decade of operations.
◆
Technology Moat
Atlasbalans: patented mechanism, German Design Award 2020, Good Design Award 2018. The only device of its kind. Fascia Guide — 250+ hours of expert podcast content. Research Database — 5,000+ curated scientific articles.
◆
Network Moat
500+ certified specialists across Sweden. A franchise system with standardised onboarding. Each new clinic strengthens the network, not just the P&L.
◆
Brand & Science Moat
Swedish Fascia Convention (250+ attendees, 20+ countries). Direct collaboration with leading fascia researchers globally. Nature-published research validates the anatomical foundation.
Expansion Strategy
Anchor Markets. Proven Model. Capital-Efficient Scale.
Each market entry follows the same playbook: identify a master franchisee with local distribution, deploy the standardised system, achieve quality-assured autonomous operations, then scale.
Phase 1
2026
Japan — Company Formation & First Clinics
LLC formation underway. In two days in Japan we made more meaningful contacts than in 15 years in Sweden — government representatives, finance partners, private and public sector. Japan experts confirmed: what you experienced is unique. Atleta partnership (master franchisee candidate) and government alignment via Nakai-san (former Diet member) in active negotiation. Hotel piggyback model enables rapid clinic deployment without dedicated premises. Potential: thousands of clinics.
Phase 2
2026–2027
USA — Preparation 2026, Launch Autumn 2027
USA market preparation begins in 2026. Target launch autumn 2027. B2B wellness and corporate health channel activation. Treatment-in-a-Box rollout in hotel/spa/corporate wellness. The Japan hotel-piggyback model copies directly to the USA, Netherlands, Germany, and Spain.
Phase 3
2028–2029
European & Global Scale
Master franchise agreements in Germany, Netherlands, UK. Knowledge platform AI-driven, generating recurring SaaS revenue. Network of 100+ clinics generating royalty income globally. When we list, we are talking about billion-SEK valuations.
Japan — Active 2026
LLC formation underway
Atleta partnership — master franchisee candidate
Under negotiation
Government alignment via Nakai-san (former Diet member)
Under negotiation
Structured Silence retreat — September 2026
¥13 trillion healthcare market
Clinic-in-a-Box — modular, deployable, quality-assured
The Team
The Team That Built This From Zero
Board of Directors
Stefan Sallerfors
Chairman
Medical doctor with background in radiology and insurance medicine. 12 years as Chairman of Spotlight Group. Confirms B2B insurance logic: FasciaClinics addresses root-cause conditions that cost insurers billions annually.
Johan Engström
Board Member
Former CEO of Fastighetsbyrån. Deep experience in franchise operations and scaling. His core insight: the more systematised the experience, the easier to recruit, onboard, and quality-assure franchisees.
Lena Bohlin
Board Member
30 years of experience in financial management from Umeå University. Ensures capital discipline and operational integrity across the group.
Fredrik Ekblom
Board Member
Strategic advisor and investor with experience from growth companies. Finance professional with background from Nordnet and Swedbank.
Thomas Strömberg
Board Member
Former Deputy CEO at Deloitte. Broad experience in audit, growth, and corporate governance.
Oskar Strålin
Auditor
Certified Public Accountant at Grant Thornton. Responsible for external audit and financial quality assurance across the group.
In-depth — 22 minutes
Get to Know the People Behind the Concept
Axel and Ivar discuss the business model, expansion strategy, and why they're raising capital now — in an unfiltered conversation.
Financial Snapshot
Track Record & Forecast
FasciaClinics has grown 3× in revenue since 2022 with positive EBITDA every year. The 2024–2025 margin dip reflects a deliberate investment phase: maturing the franchise system, quality-assuring every process, and building the international infrastructure. The heaviest investments are behind us. From 2026, we harvest.
Franchise Maturity Insight
FasciaClinics has started 33 clinics over 4 years. 16 are active today — all with a 4.9-star average across 1,200+ reviews. The ones that closed contributed treatments, customer data and brand awareness while they operated. The system has naturally selected its best operators.
"In with ten therapists. Five might crash. But five get traction. In with ten more. Five more get traction. You need to reach critical mass in franchise." — Johan Engström, former CEO Fastighetsbyrån
2022
7.9 MSEK
Actual revenue
2023
16.7 MSEK
Actual revenue
+111%
2024
20.4 MSEK
Actual revenue
+22%
2025P
23 MSEK
Preliminary
+13%
2026P
40 MSEK
Forecast
+74%
2029P
200 MSEK
Target
Revenue (MSEK) — Sweden + International
7.9M
2022
16.7M
2023
20.4M
2024
23M
2025P
40M
2026P
85M
2027P
150M
2028P
200M
2029P
Sweden
International
Projected
FasciaClinics — Revenue & EBITDA (MSEK)
| 2022 | 2023 | 2024 | 2025P | 2026P | 2027P | 2028P | 2029P | |
|---|---|---|---|---|---|---|---|---|
| Revenue (MSEK) | 7.9 | 16.7 | 20.4 | 23 | 40 | 85 | 150 | 200 |
| EBITDA (MSEK) | 1.7 | 2.4 | 1.1 | 0.7 | 4 | 12 | 28 | 44 |
| EBITDA margin | 22% | 14% | 5% | 3% | 10% | 14% | 19% | 22% |
| New units started | 6 | 13 | 4 | 10 | 25 | 70 | 110 | 160 |
Revenue Breakdown by Market (MSEK)
| 2025P | 2026P | 2027P | 2028P | 2029P | |
|---|---|---|---|---|---|
| Sweden (MSEK) | 23 | 38 | 55 | 80 | 100 |
| Japan (MSEK) | — | 2 | 20 | 45 | 65 |
| Hotel partners (MSEK) | — | — | 8 | 18 | 25 |
| USA (MSEK) | — | — | 2 | 7 | 10 |
| Total revenue (MSEK) | 23 | 40 | 85 | 150 | 200 |
What the Numbers Don't Show Yet
The current revenue base reflects Sweden only. The first master franchise agreement — covering a country or region — generates an upfront license fee plus ongoing royalties from every treatment performed in that market. As the network scales to 500+ units globally, the royalty base compounds. Central costs grow slower than revenue at every stage.
Valuation Context
Current valuation: SEK 265M (€23M). 2029 target EBITDA: SEK 44M (€3.8M). That implies an entry multiple of ~6× 2029 EBITDA — extremely conservative for a scaling franchise platform with recurring royalty income and global expansion underway.
EUR figures at 1 EUR = 11.5 SEK. All projections are management estimates.
The Opportunity
Why This. Why Now.
FasciaClinics has spent 16 years proving the model without institutional capital. The crowdfunding rounds validated community demand — approximately 500 investors believed in this before the international story was written. The next phase is about scale.
Japan changed everything. In two days we made more meaningful contacts than in 15 years in Sweden. A company is being formed. Government-level dialogue is underway. Japan experts said: what you experienced is unique. Roadmap: Japan 2026, USA 2027.
We are not looking for passive capital. We are looking for partners who understand what category creation looks like — and who want to be part of building the Anytime Fitness of fascia-based care.
Use of Funds
Production scaling (Atlasbalans) + international market entry + franchise system infrastructure
Round Type
Angel investors, family offices, institutional
Stage
Post-revenue, pre-scale
Valuation
SEK 265M (€23M) — grown from SEK 100M over 4 years. Management believes this is conservative.
Comparables
Anytime Fitness (franchise), Therabody (device), Mindbody (platform)
Return Thesis
Revenue Path
100+ clinics × franchise royalties per treatment + unit startup fees + master franchise license fees per new market = multiple revenue streams scaling simultaneously.
Exit Horizon
2029 target. Strategic acquirer (global wellness group, insurance company, PE roll-up) or listing on Nordic exchange.
Risk Mitigation
Profitable franchise model already proven. Franchisee bears operational risk. Asset-light model. No single point of failure.
Downside Protection
Even at conservative growth, every active clinic generates ongoing royalty income. The royalty base is recurring and compounds with each new unit — regardless of machine sales or platform revenue.